
Cidofovir
CAS No. 113852-37-2
Cidofovir ( GS-0504 | HPMPC | (S)-HPMPC )
产品货号. M10487 CAS No. 113852-37-2
西多福韦二磷酸酯的前药,通过选择性抑制病毒 DNA 聚合酶来抑制巨细胞病毒 (CMV) 病毒复制。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥251 | 有现货 |
![]() ![]() |
10MG | ¥389 | 有现货 |
![]() ![]() |
50MG | ¥656 | 有现货 |
![]() ![]() |
100MG | ¥1029 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称Cidofovir
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述西多福韦二磷酸酯的前药,通过选择性抑制病毒 DNA 聚合酶来抑制巨细胞病毒 (CMV) 病毒复制。
-
产品描述The prodrug of cidofovir diphosphate that inhibits cytomegalovirus (CMV) viral replication by selectively inhibiting viral DNA polymerases; also incorporates itself into viral DNA hence inhibiting viral DNA synthesis during reproduction.CMV Infection Approved(In Vitro):Cidofovir (5-100 μM, 72 hours) has antiviral activity against feline herpesvirus type-1 (FHV-1) with an IC50 of 11 μM, and can reduce Crandell-Reese feline kidney cell counts in a dose-dependent manner.Cidofovir (10-1000 μM, 24-120 hours) can reduce cancer cell viability and induces apoptosis.(In Vivo):Cidofovir (subcutaneous injection, 100 mg/kg, 3-6 days interval, 21 days) is highly protective against death from cowpox virus (CPV) infection at high doses in female weanling BALB/c mice.
-
体外实验Cidofovir (5-100 μM, 72 hours) has antiviral activity against feline herpesvirus type-1 (FHV-1) with an IC50 of 11 μM, and can reduce Crandell-Reese feline kidney cell counts in a dose-dependent manner.Cidofovir (10-1000 μM, 24-120 hours) can reduce cancer cell viability and induces apoptosis. Cell Cytotoxicity AssayCell Line:Crandell-Reese feline kidney(CRFK) cellsConcentration:10-100 μMIncubation Time:72 hoursResult:Reduced CRFK cells by 9.1%.Cell Viability Assay Cell Line:Caco-2, FTC-133, HeLa, Hep-G2, MDA-MB-231, NCI-H1975 and PC-3 cells Concentration:10-1000 μM Incubation Time:24, 48, 72, 96, 120 hoursResult:Resulted in a gradual decrease in tumor cell viability with time and concentration increasing and inhibited the number of FTC-133 cell clones by about 55% at 100 μM comparing to the untreated group.Apoptosis Analysis Cell Line:FTC-133 cells Concentration:100 μM Incubation Time:96 hours Result:Showed a significant increase in the expression of pro-apoptotic proteins, such as cytochrome c, phospho-p53 (S15) and caspase-3 by 130%, 49%, and 46%, respectively while the anti-apoptotic protein Bcl-x decreased significantly by 57% comparing to the untreated cells.
-
体内实验Cidofovir (subcutaneous injection, 100 mg/kg, 3-6 days interval, 21 days) is highly protective against death from cowpox virus (CPV) infection at high doses in female weanling BALB/c mice. Animal Model:Female weanling BALB/c mice infected with cowpox virus (CPV)Dosage:100 mg/kgAdministration:Subcutaneous injection; 3-6 days interval; 21 days Result:Prevented 80-100% of mouse deaths when administered on the first 4-3 days before infection.Protected 35-50% of mice when administered on the fourth day after infection, and 10-20% when administered on the sixth day.
-
同义词GS-0504 | HPMPC | (S)-HPMPC
-
通路Microbiology/Virology
-
靶点CMV
-
受体DNA/RNASynthesis
-
研究领域Infection
-
适应症CMV Infection
化学信息
-
CAS Number113852-37-2
-
分子量279.187
-
分子式C8H14N3O6P
-
纯度>98% (HPLC)
-
溶解度H2O: 6.4 mg/mL (Need warming)
-
SMILESOC[C@@H](OCP(O)(O)=O)CN1C=CC(N)=NC1=O
-
化学全称Phosphonic acid, P-[[(1S)-2-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]-
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册




关联产品
-
Tomeglovir
Tomeglovir (BAY 384766) 是一种有效的、高选择性的、非核苷类巨细胞病毒 (CMV) 复制抑制剂。
-
CFI02
CFI02 (CFI-02) 是人巨细胞病毒 (HCMV) 糖蛋白 B 介导的融合的特异性抑制剂,针对实验室适应的 HCMV 毒株 AD169,IC50 为 40 nM。
-
Cidofovir dihydrate
西多福韦二磷酸酯的前药,通过选择性抑制病毒 DNA 聚合酶来抑制巨细胞病毒 (CMV) 病毒复制。